MCID: RTC005
MIFTS: 49

Reticulosarcoma

Categories: Rare diseases, Cancer diseases, Immune diseases

Aliases & Classifications for Reticulosarcoma

MalaCards integrated aliases for Reticulosarcoma:

Name: Reticulosarcoma 12 14 69
Lymphoma, Large-Cell 72 49
Diffuse Large B-Cell Lymphoma 69
Lymphoma, Non-Hodgkin 41
Histiocytic Lymphoma 12
Large-Cell Lymphomas 12
Large Cell Lymphoma 49
Histiocytic Sarcoma 69
Lymphoma Large Cell 51

Classifications:



Summaries for Reticulosarcoma

MalaCards based summary : Reticulosarcoma, also known as lymphoma, large-cell, is related to alk-positive anaplastic large cell lymphoma and intravascular large b-cell lymphoma. An important gene associated with Reticulosarcoma is ALK (ALK Receptor Tyrosine Kinase), and among its related pathways/superpathways are NF-kappaB Signaling and IL12-mediated signaling events. The drugs Adcetris and Dexamethasone have been mentioned in the context of this disorder. Affiliated tissues include b cells, bone and t cells, and related phenotypes are endocrine/exocrine gland and hematopoietic system

Wikipedia : 72 Anaplastic large-cell lymphoma (ALCL) is a type of non-Hodgkin lymphoma involving aberrant T cells or... more...

Related Diseases for Reticulosarcoma

Diseases related to Reticulosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 94)
# Related Disease Score Top Affiliating Genes
1 alk-positive anaplastic large cell lymphoma 33.2 ALK CCND3 MUC1 NPM1
2 intravascular large b-cell lymphoma 32.7 B2M BCL6
3 primary cutaneous anaplastic large cell lymphoma 32.5 ALK GZMB MUC1 NPM1 PTPRC TIA1
4 anaplastic large cell lymphoma 32.4 ALK CLU GZMB MUC1 NPM1 PAX5
5 reticulum cell sarcoma 31.7 MUC1 PTPRC TNFRSF8
6 lymphoma, non-hodgkin, familial 31.5 ALK B2M BCL6 CASP3 CCND3 GZMB
7 lymphosarcoma 30.7 BCL6 PTPRC
8 lymphoma 29.6 ALK BCL6 NPM1 PAX5 TIA1 TNFRSF8
9 alk-negative anaplastic large cell lymphoma 12.5
10 lymphoma, large-cell, immunoblastic 12.3
11 anaplastic small cell lymphoma 11.5
12 primary mediastinal large b-cell lymphoma 11.3
13 langerhans cell histiocytosis 11.0
14 breast lymphoma 10.5 ALK BCL6
15 heart lymphoma 10.5 BCL6 PTPRC
16 testicular lymphoma 10.5 BCL6 PTPRC
17 orbit lymphoma 10.5 GZMB TIA1
18 lichen sclerosus et atrophicus 10.5 GZMB TIA1
19 lymphomatoid granulomatosis 10.5 GZMB TIA1
20 viral esophagitis 10.4 GZMB TIA1
21 subcutaneous panniculitis-like t-cell lymphoma 10.4 GZMB TIA1
22 lymphocytic gastritis 10.4 GZMB TIA1
23 natural killer cell leukemia 10.4 GZMB TIA1
24 t-cell/histiocyte rich large b cell lymphoma 10.4 BCL6 TNFRSF8
25 intraocular lymphoma 10.4 BCL6 PAX5
26 hepatosplenic t-cell lymphoma 10.4 GZMB TIA1
27 conventional fibrosarcoma 10.4 PTPRC TNFRSF8
28 choriocarcinoma of the testis 10.4 GZMB TIA1
29 primary central nervous system lymphoma 10.4 BCL6 PAX5
30 adult lymphoma 10.4 ALK TNFRSF8
31 testicular infarct 10.4 PTPRC TNFRSF8
32 malignant leydig cell tumor 10.4 PAX5 TNFRSF8
33 giardiasis 10.3 GZMB TIA1
34 histiocytic and dendritic cell cancer 10.3 CLU PTPRC
35 nodular lymphocyte predominant hodgkin lymphoma 10.3 BCL6 PAX5 PTPRC
36 primary effusion lymphoma 10.3 BCL6 CASP3
37 infiltrating lipoma 10.3 GZMB TIA1
38 epidural neoplasm 10.3 BCL6 PTPRC TNFRSF8
39 multicentric castleman disease 10.3 BCL6 PAX5
40 mediastinal malignant lymphoma 10.2 BCL6 PAX5 TNFRSF8
41 mediastinal gray zone lymphoma 10.2 BCL6 PAX5 TNFRSF8
42 cutaneous t cell lymphoma 10.2 GZMB TIA1 TNFRSF8
43 lymphoblastic lymphoma 10.2 BCL6 PTPRC TRB
44 lymphomatoid papulosis 10.1 ALK GZMB NPM1 TIA1
45 peripheral t-cell lymphoma 10.1 ALK BCL6 GZMB TIA1
46 immune system organ benign neoplasm 10.1 PTPRC TNFRSF8
47 mature b-cell neoplasm 10.1 B2M BCL6 PTPRC
48 thyroiditis 10.1
49 colon lymphoma 10.1 ALK BCL6 PTPRC TNFRSF8
50 composite lymphoma 10.1 BCL6 GZMB PAX5 TIA1

Graphical network of the top 20 diseases related to Reticulosarcoma:



Diseases related to Reticulosarcoma

Symptoms & Phenotypes for Reticulosarcoma

MGI Mouse Phenotypes related to Reticulosarcoma:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 endocrine/exocrine gland MP:0005379 9.86 ALK ANPEP B2M BCL6 CASP3 CCND3
2 hematopoietic system MP:0005397 9.85 ANPEP B2M BCL6 CASP3 CCND3 NPM1
3 immune system MP:0005387 9.7 ANPEP B2M BCL6 CASP3 CCND3 CLU
4 neoplasm MP:0002006 9.1 PTPRC ALK B2M CCND3 NPM1 PAX5

Drugs & Therapeutics for Reticulosarcoma

FDA approved drugs:

# Drug Name Active Ingredient(s) 17 Company Approval Date
1
Adcetris 17 45 BRENTUXIMAB VEDOTIN Seattle Genetics August 2011

Drugs for Reticulosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 499)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-02-2 5743
2
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 23214-92-8 31703
3
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
4
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 33419-42-0 36462
5
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
6
Cytarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 147-94-4 6253
7
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1 1959-05-2, 59-05-2 126941
8
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-18-0, 6055-19-2 2907
9
Gemcitabine Approved Phase 4,Phase 3,Phase 2,Phase 1 95058-81-4 60750
10
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 174722-31-7 10201696
11
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1 3778-73-2 3690
12
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
13
Mechlorethamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 51-75-2 4033
14 Thiotepa Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 52-24-4 5453
15
Lenograstim Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 135968-09-1
16
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
17
Vindesine Approved, Investigational Phase 4 53643-48-4, 59917-39-4 40839
18
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 53-03-2 5865
19
Epirubicin Approved Phase 4,Phase 2 56420-45-2 41867
20
Crizotinib Approved Phase 4,Phase 2,Phase 1 877399-52-5 11626560 10366136 10366137 10366138 10366139 10366140 10366141
21
leucovorin Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 58-05-9 143 6006
22
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 59-30-3 6037
23
Doxil Approved June 1999 Phase 4,Phase 3,Phase 2,Phase 1 31703
24
Pirarubicin Investigational Phase 4 72496-41-4
25 Prednisolone acetate Phase 4,Phase 3,Phase 2,Phase 1
26 Dexamethasone acetate Phase 4,Phase 3,Phase 2,Phase 1 1177-87-3
27 Isophosphamide mustard Phase 4,Phase 3,Phase 2,Phase 1 0
28 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
29 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1
30 Methylprednisolone acetate Phase 4,Phase 3,Phase 2,Phase 1
31 Methylprednisolone Hemisuccinate Phase 4,Phase 3,Phase 2,Phase 1
32 Folic Acid Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
33 Gastrointestinal Agents Phase 4,Phase 3,Phase 2,Phase 1
34 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
35 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
36 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
37 Dermatologic Agents Phase 4,Phase 3,Phase 2,Phase 1
38 Vitamin B Complex Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
39 Hormones Phase 4,Phase 3,Phase 2,Phase 1
40 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
41 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1
42 Antibodies, Monoclonal Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
43 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
44 Antiemetics Phase 4,Phase 3,Phase 2,Phase 1
45 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
46 Immunoglobulins Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
47 Etoposide phosphate Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
48 Antilymphocyte Serum Phase 4,Phase 2,Phase 3,Phase 1
49 Prednisolone hemisuccinate Phase 4,Phase 3,Phase 2,Phase 1
50 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 876)

# Name Status NCT ID Phase Drugs
1 Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old. Unknown status NCT00429065 Phase 4 Rituximab
2 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4 cyclophosphamide;thiotepa
3 Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults Completed NCT00199082 Phase 4 Adriamycin;Cyclophosphamide;Cytarabine;Dexamethasone/Prednisolone;VP16;Ifosfamide;Methotrexate;G-CSF;Rituximab;Vincristine/Vindesine
4 CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL Recruiting NCT02533700 Phase 4 CEOP/IVE/GDP chemotherapy regimen;CEOP chemotherapy regimen for 6 cycles
5 Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma Active, not recruiting NCT01909934 Phase 4 brentuximab vedotin
6 CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma Active, not recruiting NCT01746992 Phase 4 Cyclophosphamide 750mg/m2;Vincristine 1.4mg/m2;Doxorubicin 50mg/m2;prednisone 60mg/m2;ifosfamide 2000mg/m2;pirarubicin 50mg/m2;pirarubicin 25mg/m2;Etoposide phosphate 100mg/m2;methotrexate 1500mg/m2
7 A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib Withdrawn NCT02487316 Phase 4 crizotinib
8 Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma Unknown status NCT00006455 Phase 3 cyclophosphamide;cytarabine;dexamethasone;doxorubicin hydrochloride;etoposide;ifosfamide;leucovorin calcium;methotrexate;therapeutic hydrocortisone;vinblastine sulfate
9 Comparison of Two Salvage Chemotherapy Regimens Before Autologous Stem Cell Transplantation With or Without Maintenance Rituximab in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00078949 Phase 3 cisplatin;cytarabine;dexamethasone;gemcitabine hydrochloride
10 Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia Unknown status NCT00445497 Phase 3 amoxicillin-clavulanate potassium;ciprofloxacin
11 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3 ketamine hydrochloride
12 Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma Unknown status NCT00052936 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
13 Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia Unknown status NCT00020865 Phase 3 cefepime hydrochloride;levofloxacin
14 Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00003815 Phase 3 carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;melphalan;prednisolone;vincristine sulfate
15 Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma Unknown status NCT00003338 Phase 2, Phase 3
16 Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma Unknown status NCT00003337 Phase 3
17 Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma Unknown status NCT00028717 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
18 Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome Unknown status NCT00002989 Phase 3 busulfan;cyclophosphamide;idarubicin;melphalan
19 Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma Unknown status NCT00003423 Phase 3 asparaginase;cyclophosphamide;cytarabine;daunorubicin hydrochloride;dexamethasone;etoposide;mercaptopurine;methotrexate;prednisolone;thioguanine;vincristine sulfate
20 Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00053768 Phase 3 EPOCH regimen;cyclophosphamide;doxorubicin hydrochloride;etoposide;prednisone;vincristine sulfate
21 High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma Unknown status NCT00003578 Phase 3 CHOP regimen;carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;melphalan;prednisone;vincristine sulfate
22 Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma Unknown status NCT00003924 Phase 3
23 Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma Completed NCT00059839 Phase 3 doxorubicin hydrochloride;mercaptopurine;methotrexate;prednisone;vinblastine sulfate;vincristine sulfate
24 Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma Completed NCT00052923 Phase 3 carmustine;cyclophosphamide;etoposide
25 Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma Completed NCT00002618 Phase 3 cytarabine;doxorubicin hydrochloride;leucovorin calcium;mercaptopurine;methotrexate;prednisone;vincristine sulfate
26 Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma Completed NCT00566228 Phase 3
27 Early On-therapy PET at First-line Treatment in Diffuse Large B-cell Lymphoma Stage IIB-IV Completed NCT00286832 Phase 3
28 R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma Completed NCT00144755 Phase 3 Darbepoetin alfa
29 ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1 Completed NCT00140595 Phase 3 rituximab;doxorubicin;cyclophosphamide
30 Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00012051 Phase 3 carmustine;cisplatin;cytarabine;dexamethasone;etoposide;ifosfamide;melphalan;methotrexate
31 Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00064116 Phase 3 CHOP regimen
32 Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications Completed NCT00799461 Phase 3
33 Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation Completed NCT00031668 Phase 3
34 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma Completed NCT00003595 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
35 Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma Completed NCT00002649 Phase 3 cyclophosphamide;etoposide
36 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
37 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3 American ginseng
38 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
39 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3 sodium ferric gluconate complex in sucrose
40 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
41 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3 ondansetron
42 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
43 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma Completed NCT00003215 Phase 3 CHOP regimen;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;leucovorin calcium;melphalan;methotrexate;methylprednisolone;mitoxantrone hydrochloride;prednisone;therapeutic hydrocortisone;vincristine sulfate
44 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
45 Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer Completed NCT00053053 Phase 3
46 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3 Fragmin
47 Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00278421 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
48 Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma Completed NCT00278408 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
49 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3 darbepoetin alfa;epoetin alfa
50 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B

Search NIH Clinical Center for Reticulosarcoma

Cochrane evidence based reviews: lymphoma, non-hodgkin

Genetic Tests for Reticulosarcoma

Anatomical Context for Reticulosarcoma

MalaCards organs/tissues related to Reticulosarcoma:

38
B Cells, Bone, T Cells, Bone Marrow, Liver, Kidney, Myeloid

Publications for Reticulosarcoma

Articles related to Reticulosarcoma:

(show top 50) (show all 74)
# Title Authors Year
1
Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice. ( 11426330 )
2001
2
In vitro and in vivo characterisation of low-resistant mouse reticulosarcoma (M5076) sublines obtained after pulse and continuous exposure to cisplatin. ( 8943689 )
1996
3
Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice. ( 2189589 )
1990
4
Treatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum (II) encapsulated in multilamellar vesicles. ( 3315188 )
1987
5
Primary reticulosarcoma of bone (non-Hodgkin's lymphoma). A study of 12 cases. ( 3503874 )
1987
6
Ultrastructural and freeze fracture localization of multilamellar liposomes containing a lipophilic cisplatin analogue in normal tissues and liver metastases of M5076 reticulosarcoma. ( 3322541 )
1987
7
Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor. ( 3100032 )
1987
8
Round-cell sarcomas of bone and their differential diagnosis (with particular emphasis on Ewing's sarcoma and reticulosarcoma). A study of 233 tumors with optical and electron microscopic techniques. ( 6763672 )
1982
9
Preliminary results of chemoradiotherapy followed (or not ) by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma: correlation of the results with WHO categorization. ( 370939 )
1978
10
Morphology of lymphoreticular tissues in mice with reticulosarcoma. ( 365565 )
1978
11
Chemotherapists' need for uniform and rational nomenclature and classification of common lymphosarcomas and reticulosarcoma (hematosarcomas or non-Hodgkin's lymphomas). ( 373918 )
1978
12
Preliminary results of chemo-radiotherapy followed or not by active immunotherapy of stage III and IV lymphosarcoma and reticulosarcoma. Correlation of the results with WHO categorisation. ( 373920 )
1978
13
Combination chemotherapy with adriamycine, VM 26, cyclophosphamide and prednisone in lymphosarcoma and reticulosarcoma stage III and IV. ( 326554 )
1977
14
Modifications of macrophage chemotaxis in rats bearing the transplantable tumour reticulosarcoma 'IRE'. ( 335481 )
1977
15
Malignant lymphoma (reticulosarcoma) in bone. ( 334431 )
1977
16
Pathogenesis of ascites in a murine transplantable reticulosarcoma type A. ( 137595 )
1976
17
Adult coeliac disease. A case with ulceration, dermatitis herpetiformis and reticulosarcoma. ( 766153 )
1976
18
Hairy cell leukemia ('leukemic reticuleondotheliosis'), reticulosarcoma, and monocytic leukemia. Cytochemical and ultrastructural investigations. ( 808067 )
1975
19
Microglioma and/or reticulosarcoma of the nervous system. ( 51573 )
1975
20
Reticulosarcoma occurring during long-term hemodialysis. ( 1092500 )
1975
21
The effect of immunostimulation and chemotherapy on the growth of reticulosarcoma in mice. ( 4618487 )
1974
22
Reticulosarcoma of vulva complicating azathioprine-treated dermatomyositis. ( 4583173 )
1973
23
Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. II. Reticulosarcoma. (Correlation with the immunity reaction of the cellular type and the clinical status). ( 4573872 )
1973
24
Blastoid lymphocyte transformation assay in malignant tumours of lymphopoietic tissue: in Hodgkin's disease, reticulosarcoma, lymphosarcoma and chronic lymphatic leukaemia. Relationship to the clinical status and to the delayed type of hypersensitivity. ( 4128515 )
1973
25
Reticulosarcoma of the vulva complicating dermatomyositis treated by immunosuppression. ( 4577331 )
1973
26
Lambda cold agglutinin with anti-A 1 specificity in a patient with reticulosarcoma. ( 4622181 )
1972
27
Reticulosarcoma and amyloid development in BALB/c mice inoculated with syngeneic cells from young and old donors. ( 4941118 )
1971
28
Cytologic studies of tumors. L. clonal proliferation of four stemlines in three hematopoietic tissues of a patient with reticulosarcoma. ( 4925076 )
1971
29
Reticulosarcoma of the stomach. Report of 13 cases with follow-up results. ( 4931920 )
1970
30
Primary cerebral reticulosarcoma. ( 4913659 )
1970
31
Cytogenetic analysis in two cases of lymphoma. Comparison between lymphosarcoma and reticulosarcoma. ( 4910257 )
1970
32
Electron microscopic study of tonsillar reticulosarcoma. I. Features of malignancy in tumor cells. ( 4886966 )
1967
33
Reticulosarcoma of the caecum. ( 5337477 )
1967
34
Electron microscopic study of tonsillar reticulosarcoma. II. Effect of radiation on tumor cells. ( 4886967 )
1967
35
Reticulosarcoma of the eye treated with cyclophosphamide. ( 5336275 )
1966
36
DISSEMINATED HISTOPLASMOSIS FOLLOWING LONG-TERM STEROID THERAPY FOR RETICULOSARCOMA. ( 14331625 )
1965
37
LYMPHOGRAPHY WITH RADIOACTIVE CONTRAST MEDIUM IN LYMPHOSARCOMA AND RETICULOSARCOMA. ( 14247471 )
1965
38
INTESTINAL RETICULOSARCOMA IN IDIOPATHIC STEATORRHOEA. ( 14273509 )
1964
39
ACQUIRED HYPOGAMMAGLOBULINAEMIA COMPLICATED BY RETICULOSARCOMA. ( 14098564 )
1963
40
Primary reticulosarcoma of the thyroid gland. ( 13742171 )
1961
41
Malignant tumours of the stomach arising from the lympho-reticular system. A report of 10 cases of lymphosarcoma and reticulosarcoma of the stomach. ( 14492653 )
1961
42
Case of Mesenteric Reticulosarcoma Associated with Gluten-sensitive Steatorrhoea. ( 20789212 )
1961
43
Reticulosarcoma complicating sarcoidosis. ( 13805580 )
1960
44
Trypan blue concentration and protein composition in sera of rats injected repeatedly with Trypan blue in relation to reticulosis and to reticulosarcoma. ( 13722875 )
1960
45
Perforating reticulosarcoma of the jejunum. ( 14420016 )
1959
46
Studies on the therapy of reticulosarcoma(-tosis) with actinomycin. ( 14445951 )
1959
47
Reticulosarcoma. ( 13653789 )
1959
48
Reticulosarcoma of both breasts. ( 13835234 )
1959
49
[A case of "malignant granuloma of the nose"; reticulosarcoma]. ( 13670636 )
1959
50
Chemotherapeutic management of reticulosarcoma. ( 14441246 )
1959

Variations for Reticulosarcoma

Expression for Reticulosarcoma

Search GEO for disease gene expression data for Reticulosarcoma.

Pathways for Reticulosarcoma

Pathways related to Reticulosarcoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.61 B2M BCL6 GZMB PAX5 PTPRC TNFRSF8
2
Show member pathways
11.38 B2M GZMB TRB
3 10.98 BCL6 PAX5 PTPRC TNFRSF8

GO Terms for Reticulosarcoma

Cellular components related to Reticulosarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 focal adhesion GO:0005925 8.92 B2M CCND3 NPM1 PTPRC

Biological processes related to Reticulosarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 adult behavior GO:0030534 9.16 ALK PAX5
2 positive regulation of NF-kappaB transcription factor activity GO:0051092 9.13 ALK CLU NPM1
3 positive regulation of receptor-mediated endocytosis GO:0048260 8.62 B2M CLU

Sources for Reticulosarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....